Loading
IARC estimates 29,044 new cancer cases and 18,661 cancer deaths in Tanzania in 2024; the commonest new cancers are cervix uteri, breast and prostate. This page is assembled automatically from OnCo's data: 2 institutions and 2 people, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 4,966 | 24.8 | Cervical cancer |
| Breast | 3,024 | 14.6 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 2,915 | 23.7 | Prostate cancer |
| Oesophagus | 2,875 | 8.5 | Oesophageal cancer |
| Colorectum | 1,957 | 5.4 | Colorectal cancer |
| Liver and intrahepatic bile ducts | 1,250 | 3.2 | Hepatocellular carcinoma |
| Stomach | 1,249 | 3.8 | Gastric & gastro-oesophageal junction cancer |
| Non-Hodgkin lymphoma | 766 | 1.6 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Kaposi sarcoma | 721 | 1.5 | Kaposi sarcoma |
| Leukaemia | 684 | 1.3 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Cervix uteri | 3,011 | 15.3 | Cervical cancer |
| Oesophagus | 2,617 | 7.9 | Oesophageal cancer |
| Prostate | 1,768 | 14.6 | Prostate cancer |
| Breast | 1,492 | 7.5 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Colorectum | 1,108 | 3.3 | Colorectal cancer |
| Liver and intrahepatic bile ducts | 1,105 | 2.9 | Hepatocellular carcinoma |
| Stomach | 1,036 | 3.2 | Gastric & gastro-oesophageal junction cancer |
| Trachea, bronchus and lung | 523 | 1.6 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Leukaemia | 467 | 1.0 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Non-Hodgkin lymphoma | 383 | 0.9 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
No trial record in OnCo lists a site in Tanzania. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
People whose main affiliation in OnCo is an institution or company in Tanzania.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Tanzania is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
A deep dive for Tanzania is ranked 35 of 60 in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.